pindolol has been researched along with Pemphigus in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.
Excerpt | Relevance | Reference |
---|---|---|
" In pemphigus erythematosus, very good results were obtained in 3 of 5 cases, and failure in 2 cases was probably related to insufficient dosage of steroids, or no treatment with steroids at all." | 1.25 | Visken as supplementary drug in the treatment of pemphigus. ( Blaszczyk, M; Chorzelski, T; Jablonska, S; Maciejowska, E, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chorzelski, T | 1 |
Jablonska, S | 1 |
Maciejowska, E | 1 |
Blaszczyk, M | 1 |
1 other study available for pindolol and Pemphigus
Article | Year |
---|---|
Visken as supplementary drug in the treatment of pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Pindolol | 1975 |